menisdaurilide: from Ouratea reticulata structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Ouratea | genus | [no description available] | Ochnaceae | A plant family of the order THEALES, subclass Dilleniidae, class Magnoliopsida that have evergreen, alternate leaves.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 155054 |
| CHEMBL ID | 454480 |
| CHEBI ID | 81370 |
| MeSH ID | M0404205 |
| Synonym |
|---|
| 2(6h)-benzofuranone, 7,7a-dihydro-6-hydroxy-, (6s,7ar)- |
| menisdaurilide |
| 67765-59-7 |
| C17900 |
| chebi:81370 , |
| CHEMBL454480 |
| DTXSID30218030 |
| Q27155307 |
| AKOS040763330 |
| Class | Description |
|---|---|
| benzofurans | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID402639 | Cytotoxicity against human BC cells by colorimetric method | 2005 | Journal of natural products, Jul, Volume: 68, Issue:7 | Bioactive constituents of the leaves of Phyllanthus polyphyllus var. siamensis. |
| AID402640 | Cytotoxicity against human NCI-H187 cells by colorimetric method | 2005 | Journal of natural products, Jul, Volume: 68, Issue:7 | Bioactive constituents of the leaves of Phyllanthus polyphyllus var. siamensis. |
| AID402638 | Cytotoxicity against human KB cells by colorimetric method | 2005 | Journal of natural products, Jul, Volume: 68, Issue:7 | Bioactive constituents of the leaves of Phyllanthus polyphyllus var. siamensis. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||